MIRA INFORM REPORT

 

 

Report Date :

17.12.2011

 

IDENTIFICATION DETAILS

 

Name :

LABORATORIOS COFAR S.A.

 

 

Registered Office :

Victor Eduardo 2293, Miraflores Bajo La Paz

 

 

Country :

Bolivia

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

20.09.1973

 

 

Legal Form :

Joint-Stock Company

 

 

Line of Business :

Manufacture, import, representation and trading of pharmaceutical products for human use.

 

 

No. of Employees :

314

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

Unknown

Litigation :

Clear

 


NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

Bolivia

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


IDENTIFICATION

 

CORRECT COMPANY NAME

LABORATORIOS COFAR S.A.

TRADE NAME

LABORATORIOS COFAR

TAXPAYER REGISTRATION

NIT 1020603028

MAIN ADDRESS

Victor Eduardo 2293, Miraflores Bajo

CITY / PROVINCE

La Paz

DEPARTAMENT / STATE

La Paz

COUNTRY

BOLIVIA

TELEPHONE

(5912) 2220352

E-MAIL

adm@cofar.com.bo

WEB

www.cofar.com.bo

COMMENTS

Another E-mail: cofar@cofar.com.bo

 

SUMMARY

 

Date of foundation                  1973

Capital stock                            Bs.3,602,200.= Bolivianos

Shareholders' equity              47,053,635.00 Bolivianos (31MAR2011)

Annual revenues                       US$ 5,655,707.91 Bolivianos (31MAR2011)

Profits (loss)                            9,913,165.00 Bolivianos (31MAR2011)

permanent employees              314

Chief Executive                          GRANIER CARDONA, ALEX

Disposition                                 Excellent.- Full information and updated figures.

Payments policy                        Without rating (No payment experience traced)

 

 

LEGAL BACKGROUNDS

 

LEGAL STATUS

Joint-Stock Company

DATE OF INCORPORATION

20SEP1973

PLACE OF REGISTRY

La Paz

CURRENT PAID-IN CAPITAL

Bs.3,602,200.= Bolivianos

SHAREHOLDERS EQUITY

47,053,635.00 Bolivianos (31MAR2011)

CLASS OF SHARES

Registered

LISTED AT STOCK EXCHANGE

No

CURRENT EXCHANGE RATE (US$)

Bs.6.91 per 1 USD

COMMENTS

The General Manager is in charge of the company's legal representation.

 

DIRECTORS - EXECUTIVES – SHAREHOLDERS

 

FULL NAMES / COMPANY NAME

TITLE

%PART.

SINCE

HANDAL KATINI, LEONARDO

President

90%

 

GRANIER CARDONA, ALEX

General Manager

 

 

ZEGARRA DEHEZA, OSCAR

Admin. & Finance Manager

 

 

RIVERA, JUAN ALBERTO

Industrial Manager

 

 

MARQUEZ, RAMIRO

General Accountant

 

 

ROJAS URQUIZO, LUIS FERNANDO

Costs & Budget Supervisor

 

 

HANDAL JAUREGUI, LEONARDO

Shareholder

05%

 

JAUREGUI DE HANDAL, CARMEN

Shareholder

05%

 

 

 

WHO IS WHO?

 

HANDAL KATINI, LEONARDO

NATIONALITY

Bolivian

 

 

ASSOCIATED AS PER OUR DATABASE TO

COMPANY

TITLE

TAX REG

COUNTRY

NOVARA S.R.L.

 

1020295022

BOLIVIA

 

 

 

 

HANDAL JAUREGUI, LEONARDO

NATIONALITY

Bolivian

 

 

ASSOCIATED AS PER OUR DATABASE TO

COMPANY

TITLE

TAX REG

COUNTRY

NOVARA S.R.L.

 

1020295022

BOLIVIA

 

 

JAUREGUI DE HANDAL, CARMEN

NATIONALITY

Bolivian

 

 

ASSOCIATED AS PER OUR DATABASE TO

COMPANY

TITLE

TAX REG

COUNTRY

NOVARA S.R.L.

 

1020295022

BOLIVIA

 

BUSINESS HISTORY

 

Subject Company was founded on September 20, 1973. To date it is one of most prestigious industrial pharmaceutical companies in Bolivia. Its Industrial Plant is located in La Paz, and currently covers the manufacture and sale of medicines. 
It has three divisions: Industiral, Commercial and Administrative and Financial Division.
 
The production of LABORATORIOS COFAR is sold through its own agencies in all the capital cities of departments and some intermediate cities, currently reaching with all the range of products to drugstores, hospitals, clinics, institutions and other clients from the four cardinal points of the country. Subject's current growth is based on the consolidation of the established products and on aggresive policies introducing new molecules in the market and an efficient process administration and production systems; with a permanent selection, evaluation and training of its human resources.

 

 

RELATED COMPANIES TO SUBJECT COMPANY OR TO MAJORITY SHAREHOLDER

 

COMPANY NAME

COUNTRY

TAX REG.

RELATION %

NOVARA S.R.L.

BOLIVIA

1020295022

Related

 

 

BUSINESS

SIC Classification
2 8 - CHEMICALS AND ALLIED PRODUCTS

Main activity

Manufacture, import, representation and trading of pharmaceutical products for human use.
 
Trademark:  "COFAR".

Import

Yes

Country

(From Germany, Chile and Switzerland)

Export

Yes

COUNTRY

(To Honduras)

% CASH SALES / METHOD

70%

% Credit SALES / Terms

30% (30-day terms)

% Ventas exterior (Paises)

03%

% DOMESTIC PURCHASES

30%

% FOREIGN PURCHASES

70%

SELLING TerritorY

Domestic and international market

EMPLOYEES

314

 

LOCATION

 

PREMISES

Own

OTHER PREMISES

The company's Headquarters operate at the address shown in the identification heading.
 
Subject has 12 sales branches; 3 in La Paz and 9 throughout the following cities: El Alto, Cochabamba, Quillacollo, Santa Cruz, Potosí, Sucre, Tarija and Trinidad (Rented Premises).

Comments

It ihas the Exclusive Representative of BRESKOT PHARMA and VIDILINE.
 

 

 

 

 

FINANCIAL INFORMATION

 

Interviewee(s)

Ramiro Márquez

Position(s)

General Accountant

Disposition

Excellent.- Full information and updated figures.

Information provided

First, we spoke with the Secretary who did not want to tell us her name. She suggested us to supplement our request by sending a presentation letter addressed to Oscar Zegarra (Administrative and Financial Manager). We immediately did it.
 
After several days insisting, Ramiro Márquez (General Accountant) finally replied our request. He confirmed operating data and provided other information of interest. Besides, he provided the main accounts of the last Balance Sheet as of 31/03/2011 (12 months and fiscal year-end).
 
We had no access to figures from the 03/2010 fiscal year.
 
From previous investigations, we have the main accounts of the Balance Sheet as of 31/03/2009 (12 months), expresseda in Bolivianos.

 

BALANCE SHEET

 

Balance sheet date

31MAR2011

31MAR2009

 

 

Type of balance sheet

Annual

Annual

 

 

Period

12 months

12 months

 

 

Currency

Bolivianos

Bolivianos

 

 

Exchange rate per US$

6.95

7.02

 

 

A S S E T S

 

 

 

 

Current Assetsd

56,056,840.00

37,134,188.00

 

 

Fixed

12,331,542.00

11,469,120.00

 

 

Total Assets

68,388,382.00

48,603,308.00

 

 

L I A B I L I T I E S

 

 

 

 

Current liabilities

18,207,213.00

9,131,088.00

 

 

Long term

3,127,534.00

2,193,496.00

 

 

TOTAL LIABILITIES

21,334,747.00

 

 

 

S H A R E H O L D E R S'  E Q U I T Y

 

 

 

 

Total shareholders equity

47,053,635.00

37,278,724.00

 

 

Total Liab. / Sh. equity

68,388,382.00

48,603,308.00

 

 

Sales

39,307,170.00

49,488,512.00

 

 

Profit (Loss)

9,913,165.00

8,976,303.00

 

 

 

RATIO

 

Liquidity ratio

3.08

Current assets ÷ Current liabilities

Debt-to-equity ratio

258.43 %

(Shareholders' equity ÷ Current liabilities %)

Profitability margin

25.22 %

(Profits ÷ Sales %)

Working capital

37,849,627.00

(Current assets - Current liabilities)

FINANCIAL SITUATION

SATISFACTORY
According to the last Financial Statement, the company's Financial Standing is considered to be Satisfactory as it has an adequate higher-than-average liquidity ratio. Working capital is positive and allows it an orderly fulfillment of payments. Debt-to-equity ratio is acceptable. Economic results have been satisfactory.
 
No adverse have been found during our investigation made in several sources.

 

 

 

 

 

INSURANCE

COMPANY

AGAINST

EXPIRATION

AMOUNT

ALIANZA COMPAÑÍA DE SEGUROS Y REASEGUROS

All risk

 

 

 

PAYMENTS RECORD: TRADE REFERENCES

 

(Confidential Information)

Supplier

Telephone

Country

Comment

Campo Iris Imprenta

(5912) 2223168

BOLIVIA

 

Select - Chemie

 

SWITZERLAND

 

Helmuth

 

GERMANY

 

Favima Ltda.

 

CHILE

 

A. Sander y Cía.

 

GERMANY

 

Matriplast S.A.

(5912) 2120521

BOLIVIA

 

 

 

BANKING INFORMATION

 

Bank

CREDITO

NACIONAL DE BOLIVIA

 

Subject is client of the above mentioned banks which when being consulted told us that according to the current legal regulations they cannot provide any information on Subject's operations under bank secrecy.

 

 

 

 

GENERAL INFORMATION

 

REPUTATION

 

 

 

NOTHING AGAINST COMPANY

 

 

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.52.81

UK Pound

1

Rs.82.00

Euro

1

Rs.68.81

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.